SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Zenas BioPharma to host R&D event on Oct. 27, 2026

Zenas BioPharma will host a virtual R&D event on Oct. 27, 2026, from 8:00 a.m. to 9:30 a.m. ET. Management will outline the R&D pipeline, with a focus on obexelimab in systemic lupus erythematosus, and updates on ZB021.

ZBIO.O